BMJ  2008;336:850-851 (19 April), doi:10.1136/bmj.39551.656875.C2

News

Australian drug industry seeks to improve its image

¹ Hobart

The first 150 words of the full text of this article appear below.

Australia’s leading drug industry lobby group, Medicines Australia, is canvassing options on how to counter what it describes as "challenges" to its "credibility and trust." The move comes after new rules were introduced making it mandatory for drug companies to publicly disclose details of their involvement in meetings and conferences for doctors (BMJ 2008;336:742; doi: 10.1136/bmj.39535.488299.DB).

The lobby group’s annual one day "members only" conference included presentations from an ethicist on "ethical conduct," a public relations adviser on "shaping a new image," and a market researcher on "moral responsibility and corporate reputation."

In the conference programme the group’s chief executive, Ian Chalmers, wrote that "there are serious issues of reputation and trust that we need to address." In an interview with the BMJ he was more circumspect. "I’m not conceding that we have a serious reputation problem," he said, "but we have a responsibility to make sure we . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Australian drug industry gives details of money spent courting doctors

Bob Burton
BMJ 2008 336: 742. [Extract] [Full Text] [PDF]

Drug industry loses bid to block disclosure of doctors' gifts

Bob Burton
BMJ 2007 335: 12-13. [Extract] [Full Text] [PDF]

Press: Sponsored journalism award shocks Australian media

Melissa Sweet
BMJ 2001 323: 1258. [Full Text]

Online poll

Find out more >>